- Home
- QURE vs HLF Comparison
QURE vs HLF Comparison
Compare QURE & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- HLF
- Stock Information
- Founded
- QURE 1998
- HLF 1980
- Country
- QURE Netherlands
- HLF United States
- Employees
- QURE N/A
- HLF N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- HLF Other Pharmaceuticals
- Sector
- QURE Health Care
- HLF Health Care
- Exchange
- QURE Nasdaq
- HLF Nasdaq
- Market Cap
- QURE 750.6M
- HLF 723.7M
- IPO Year
- QURE 2007
- HLF N/A
- Fundamental
- Price
- QURE $16.98
- HLF $6.48
- Analyst Decision
- QURE Strong Buy
- HLF Buy
- Analyst Count
- QURE 8
- HLF 5
- Target Price
- QURE $32.43
- HLF $9.90
- AVG Volume (30 Days)
- QURE 4.7M
- HLF 2.7M
- Earning Date
- QURE 11-05-2024
- HLF 02-12-2025
- Dividend Yield
- QURE N/A
- HLF N/A
- EPS Growth
- QURE N/A
- HLF N/A
- EPS
- QURE N/A
- HLF 0.85
- Revenue
- QURE $28,587,000.00
- HLF $5,000,700,000.00
- Revenue This Year
- QURE $150.65
- HLF N/A
- Revenue Next Year
- QURE N/A
- HLF $1.79
- P/E Ratio
- QURE N/A
- HLF $7.60
- Revenue Growth
- QURE N/A
- HLF N/A
- 52 Week Low
- QURE $3.73
- HLF $6.35
- 52 Week High
- QURE $17.71
- HLF $15.50
- Technical
- Relative Strength Index (RSI)
- QURE 75.89
- HLF 28.44
- Support Level
- QURE $14.68
- HLF $6.98
- Resistance Level
- QURE $17.71
- HLF $7.50
- Average True Range (ATR)
- QURE 1.58
- HLF 0.39
- MACD
- QURE 0.64
- HLF -0.17
- Stochastic Oscillator
- QURE 93.71
- HLF 6.19
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About HLF Herbalife Ltd.
Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management; targeted nutrition; Energy, Sports, and Fitness; Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Mexico, South and Central America, EMEA, Asia-Pacific, and China.